Project cooperationUpdated on 16 January 2026
Seeking In Silico Modelling for Nanofiber-Based Cancer "Ecological Traps"
Strategy & Research Associate at Migration Biotherapeutics
Cambridge, United Kingdom
About
Migration Biotherapeutics is a UK-based start-up developing the ALIGHT device, a first-in-class "ecological trap" for Glioblastoma (GBM). Our technology utilises electrospun PCL nanofibers to physically redirect invasive tumour cells through contact guidance, preventing infiltration into healthy brain tissue.
For the HORIZON-MISS-2026-02-CANCER-01 call, we are seeking university-based research partners with expertise in in-silico computational modelling and Virtual Human Twin (VHT) development. We aim to create predictive digital models of our device’s physical steering mechanisms to accelerate R&D and provide performance data for First-in-Human trials. This collaboration will help validate the device's efficacy in a virtual environment, significantly de-risking the clinical translation process.
Stage
- Design - setting the project scope
- Completing the consortia
Topic
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
Type
- Consortium/Coordinator seeks Partners
- Offering Expertise to Consortias
Organisation
Similar opportunities
Project cooperation
Partner Search: 3D Organoid Expertise for High-Fidelity GBM Device Validation
- Completing the consortia
- Offering Expertise to Consortias
- Design - setting the project scope
- Consortium/Coordinator seeks Partners
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Enoch Alex
Strategy & Research Associate at Migration Biotherapeutics
Cambridge, United Kingdom
Project cooperation
Facilitating contacts with cancer researchers at Medical University of Vienna
- Completing the consortia
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Reinhard Eckert
Research Service at Medical University of Vienna
Vienna, Austria
Project cooperation
- Completing the consortia
- Offering Expertise to Consortias
- Design - setting the project scope
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Dani Ortiz
representador legal at TORMENTA‑IA3, SL
Madrid, Spain